Health Condition 1: O992- Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: Vitamin B 12: A daily doses of 50 micrograms of vitamin b12 will be given from enrollment 3-6 weeks post-partum
Control Intervention1: Microcrystalline cellulose: A daily dose of 50 mg
Sponsors
Pacific institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women aged more than equal to 18 years who will present for antenatal care before or at 14 weeks of gestational age as judged by the last menstrual period willing to provide informed consent and comply with study procedures will be eligible for inclusion.
Exclusion criteria
Exclusion criteria: Those who anticipated moving out of the area before study completion Who had twin or multiple pregnancies, Those who were treated for infertility Who tested positive for Hepatitis B Hepatitis B surface antigen HIV or Syphilis Venereal Disease Research Laboratory test infections, or Who was taking daily vitamin supplements in addition to folic acid and iron Women with a serious preexisting medical condition defined as the need for chronic or daily medication use.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Infant anthropometric parameters & neurodevelopmental statusTimepoint: At birth & six months of age | — |
Primary
| Measure | Time frame |
|---|---|
| Infant vitamin b12 status at birth and at 6 months of age assessed by serum vitamin b12 levels Timepoint: at birth and at 6 months of age | — |
Countries
India
Contacts
Public ContactDr suresh chandra goyel
Pacific institute of medical sciences
Outcome results
None listed